Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Papilledema from gain-of-function mutations in the STAT3 gene

Full metadata record
DC Field Value Language
dc.contributor.authorSuh, Young-Woo-
dc.contributor.authorHorton, Jonathan C.-
dc.date.accessioned2021-09-01T17:51:51Z-
dc.date.available2021-09-01T17:51:51Z-
dc.date.created2021-06-19-
dc.date.issued2019-03-04-
dc.identifier.issn1381-6810-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/67016-
dc.description.abstractBackground: Signal Transducer and Activator of Transcription 3 (STAT3) gain-of-function germline mutations are associated with diverse clinical manifestations, including autoimmune cytopenia, lymphadenopathy, immunodeficiency, endocrinopathy, and enteropathy. We describe a new feature: raised intracranial pressure with papilledema. Materials and Methods: Report of two cases. Results: The first patient had a de novo heterozygous c.2144C>T (p.Pro715Leu) mutation in the STAT3 gene. At age 1 she had papilledema with marked sheathing of the proximal vessels on the optic discs. Follow-up 8 years later showed chronic papilledema, cystoid macular edema, and vision loss. The second patient had a de novo heterozygous c.2147C>T (p.Thr716Met) mutation. At age 12 he developed papilledema, which recurred despite treatment. In both patients, repeated sampling of the cerebrospinal fluid demonstrated a lymphocytic pleocytosis. Conclusions: Papilledema can occur as a manifestation of STAT3 gain-of-function mutation, sometimes accompanied by prominent vascular sheathing and cystoid macular edema. The mechanism may be chronic meningeal infiltration by white blood cells, impairing cerebrospinal fluid absorption.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherTAYLOR & FRANCIS INC-
dc.subjectSIGNAL TRANSDUCER-
dc.subjectEVANS-SYNDROME-
dc.subjectACTIVATOR-
dc.titlePapilledema from gain-of-function mutations in the STAT3 gene-
dc.typeArticle-
dc.contributor.affiliatedAuthorSuh, Young-Woo-
dc.identifier.doi10.1080/13816810.2019.1592202-
dc.identifier.scopusid2-s2.0-85063900476-
dc.identifier.wosid000464635800001-
dc.identifier.bibliographicCitationOPHTHALMIC GENETICS, v.40, no.2, pp.165 - 169-
dc.relation.isPartOfOPHTHALMIC GENETICS-
dc.citation.titleOPHTHALMIC GENETICS-
dc.citation.volume40-
dc.citation.number2-
dc.citation.startPage165-
dc.citation.endPage169-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaGenetics & Heredity-
dc.relation.journalResearchAreaOphthalmology-
dc.relation.journalWebOfScienceCategoryGenetics & Heredity-
dc.relation.journalWebOfScienceCategoryOphthalmology-
dc.subject.keywordPlusSIGNAL TRANSDUCER-
dc.subject.keywordPlusEVANS-SYNDROME-
dc.subject.keywordPlusACTIVATOR-
dc.subject.keywordAuthorEvans syndrome-
dc.subject.keywordAuthorcystoid macular edema-
dc.subject.keywordAuthortranscription factor-
dc.subject.keywordAuthorsignal transducer and activator of transcription-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE